跳至主要内容
临床试验/KCT0002301
KCT0002301招募中未知

Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and feet (OJS) - A Randomized, Double-blinded, Placebo Controlled, Multi-center Pilot Study

Gachon University0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 59(Year)(—)
性别
Female

入选标准

  • Female aged 19 to 59 years have a complaint of cold hypersensitivity on hands and feet
  • - Subject must include at least one or more of the following symptoms below:
  • Subject has the symptoms of cold hands and feet in normal temperature which most individuals feel no cold
  • Subject has the symptoms of severe cold hands and feet in colder than normal temperature exposure
  • Even subject is on the return to a warmer environment, the symptoms of cold hands and feet is not completely
  • disappeared
  • - When subject's both upper arms exposure to room temperature (24?±2), the thermal deviation between the palm (PC8)
  • and the upper arm (LU4) may be higher than 0.3?
  • - Ability to comply with all study-related procedures, medications, and evaluations
  • - Ability to give informed consent

排除标准

  • - Patients who are admission to calcium antagonists and beta-blockers as a treatment of cold hypersensitivity on hands
  • - Patients who are having one or more finger gangrene or ulceration
  • - Patients who are diagnosed by hyperthyroidism or currently medicated to thyroid drugs
  • - Patients who are diagnosed by Autoimmune disease or having a positive antinuclear antibody(ANA) test
  • - Patients who are diagnosed by Carpal Tunnel Syndrome or having a positive Tinel's sign and Phalen's tests
  • - Patients who are diagnosed with Cervical disc herniation
  • - Patients who are diagnosed with diabetes
  • - Drug that may affect to the cold hypersensitivity on hands and feet(ex. anticoagulants)
  • - Moderate level of liver dysfunction(each of AST, ALT greater than 100 IU/L) or kidney dysfunction patient(creatine 2.0mg/dL)
  • - Due to the behaviour disorder or depression or anxiety neurosis or schizophrenia or serious mental illness, do not cooperate with treatment and follow up
  • - Diagnosed with moderate anemia and hematologic disorders
  • (adult non-pregnant women hemoglobin level less than 7g/dL, hematocrit level less than 26%, white blood cell level greater than 11,000/mm3)
  • - Systolic BP 180mmHg or diastolic blood pressure is greater than 100 mmHg based on average value of at least 2 measurements
  • - Suspected arrhythmia that showed up on ECG or diagnosed by heart disease, such as, ischemic heart disease
  • - Alcohol or drug abuse
  • - Female patients who are pregnant (positive urin - human chorionic gonadotropin) or lactating or have the chances of pregnancy
  • - Diagnosed with malignant tumors
  • - Participated in other clinical trials
  • - Refused to participate in this trial
  • - Able to understand and speak Korean
  • - Patients who are judged to be inappropriate for the clinical study by the researchers

研究者

相似试验